Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Cerebral blood volume alterations in the perilesional areas in the rat brain after traumatic brain injury--comparison with behavioral outcome.

Immonen R, Heikkinen T, Tähtivaara L, Nurmi A, Stenius TK, Puoliväli J, Tuinstra T, Phinney AL, Van Vliet B, Yrjänheikki J, Gröhn O.

J Cereb Blood Flow Metab. 2010 Jul;30(7):1318-28. doi: 10.1038/jcbfm.2010.15. Epub 2010 Feb 10.

2.

Altered levels and distribution of IGF-II/M6P receptor and lysosomal enzymes in mutant APP and APP + PS1 transgenic mouse brains.

Amritraj A, Hawkes C, Phinney AL, Mount HT, Scott CD, Westaway D, Kar S.

Neurobiol Aging. 2009 Jan;30(1):54-70. Epub 2007 Jun 11.

PMID:
17561313
3.

Cortical neuronal and glial pathology in TgTauP301L transgenic mice: neuronal degeneration, memory disturbance, and phenotypic variation.

Murakami T, Paitel E, Kawarabayashi T, Ikeda M, Chishti MA, Janus C, Matsubara E, Sasaki A, Kawarai T, Phinney AL, Harigaya Y, Horne P, Egashira N, Mishima K, Hanna A, Yang J, Iwasaki K, Takahashi M, Fujiwara M, Ishiguro K, Bergeron C, Carlson GA, Abe K, Westaway D, St George-Hyslop P, Shoji M.

Am J Pathol. 2006 Oct;169(4):1365-75.

4.

Cyclohexanehexol inhibitors of Abeta aggregation prevent and reverse Alzheimer phenotype in a mouse model.

McLaurin J, Kierstead ME, Brown ME, Hawkes CA, Lambermon MH, Phinney AL, Darabie AA, Cousins JE, French JE, Lan MF, Chen F, Wong SS, Mount HT, Fraser PE, Westaway D, St George-Hyslop P.

Nat Med. 2006 Jul;12(7):801-8. Epub 2006 Jun 11.

PMID:
16767098
5.

Enhanced sensitivity of dopaminergic neurons to rotenone-induced toxicity with aging.

Phinney AL, Andringa G, Bol JG, Wolters ECh, van Muiswinkel FL, van Dam AM, Drukarch B.

Parkinsonism Relat Disord. 2006 May;12(4):228-38. Epub 2006 Feb 20.

PMID:
16488175
6.

Stereological analysis of the reorganization of the dentate gyrus following entorhinal cortex lesion in mice.

Phinney AL, Calhoun ME, Woods AG, Deller T, Jucker M.

Eur J Neurosci. 2004 Apr;19(7):1731-40.

PMID:
15078547
7.

In vivo reduction of amyloid-beta by a mutant copper transporter.

Phinney AL, Drisaldi B, Schmidt SD, Lugowski S, Coronado V, Liang Y, Horne P, Yang J, Sekoulidis J, Coomaraswamy J, Chishti MA, Cox DW, Mathews PM, Nixon RA, Carlson GA, St George-Hyslop P, Westaway D.

Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):14193-8. Epub 2003 Nov 14.

8.

Mouse models of Alzheimer's disease: the long and filamentous road.

Phinney AL, Horne P, Yang J, Janus C, Bergeron C, Westaway D.

Neurol Res. 2003 Sep;25(6):590-600. Review.

PMID:
14503012
9.

Comparison of commissural sprouting in the mouse and rat fascia dentata after entorhinal cortex lesion.

Del Turco D, Woods AG, Gebhardt C, Phinney AL, Jucker M, Frotscher M, Deller T.

Hippocampus. 2003;13(6):685-99.

PMID:
12962314
10.

Therapeutically effective antibodies against amyloid-beta peptide target amyloid-beta residues 4-10 and inhibit cytotoxicity and fibrillogenesis.

McLaurin J, Cecal R, Kierstead ME, Tian X, Phinney AL, Manea M, French JE, Lambermon MH, Darabie AA, Brown ME, Janus C, Chishti MA, Horne P, Westaway D, Fraser PE, Mount HT, Przybylski M, St George-Hyslop P.

Nat Med. 2002 Nov;8(11):1263-9. Epub 2002 Oct 15.

PMID:
12379850
11.

Cholinergic changes in the APP23 transgenic mouse model of cerebral amyloidosis.

Boncristiano S, Calhoun ME, Kelly PH, Pfeifer M, Bondolfi L, Stalder M, Phinney AL, Abramowski D, Sturchler-Pierrat C, Enz A, Sommer B, Staufenbiel M, Jucker M.

J Neurosci. 2002 Apr 15;22(8):3234-43.

12.

New developments in animal models of Alzheimer's disease.

Janus C, Phinney AL, Chishti MA, Westaway D.

Curr Neurol Neurosci Rep. 2001 Sep;1(5):451-7. Review.

PMID:
11898556
13.

Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695.

Chishti MA, Yang DS, Janus C, Phinney AL, Horne P, Pearson J, Strome R, Zuker N, Loukides J, French J, Turner S, Lozza G, Grilli M, Kunicki S, Morissette C, Paquette J, Gervais F, Bergeron C, Fraser PE, Carlson GA, George-Hyslop PS, Westaway D.

J Biol Chem. 2001 Jun 15;276(24):21562-70. Epub 2001 Mar 15.

14.

Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid.

Calhoun ME, Burgermeister P, Phinney AL, Stalder M, Tolnay M, Wiederhold KH, Abramowski D, Sturchler-Pierrat C, Sommer B, Staufenbiel M, Jucker M.

Proc Natl Acad Sci U S A. 1999 Nov 23;96(24):14088-93.

15.

Cerebral amyloid induces aberrant axonal sprouting and ectopic terminal formation in amyloid precursor protein transgenic mice.

Phinney AL, Deller T, Stalder M, Calhoun ME, Frotscher M, Sommer B, Staufenbiel M, Jucker M.

J Neurosci. 1999 Oct 1;19(19):8552-9.

16.

No hippocampal neuron or synaptic bouton loss in learning-impaired aged beta-amyloid precursor protein-null mice.

Phinney AL, Calhoun ME, Wolfer DP, Lipp HP, Zheng H, Jucker M.

Neuroscience. 1999;90(4):1207-16.

PMID:
10338291
17.

Hippocampal neuron and synaptophysin-positive bouton number in aging C57BL/6 mice.

Calhoun ME, Kurth D, Phinney AL, Long JM, Hengemihle J, Mouton PR, Ingram DK, Jucker M.

Neurobiol Aging. 1998 Nov-Dec;19(6):599-606.

PMID:
10192220
18.

Neuron loss in APP transgenic mice.

Calhoun ME, Wiederhold KH, Abramowski D, Phinney AL, Probst A, Sturchler-Pierrat C, Staufenbiel M, Sommer B, Jucker M.

Nature. 1998 Oct 22;395(6704):755-6. No abstract available.

PMID:
9796810

Supplemental Content

Loading ...
Support Center